Wysa
Wysa's AI-enabled chatbot will be accessible to patients between visits with psychiatrists and behavioral health specialists.
However, these tools are not yet able to provide personalised advice.
Ramakant Vempati, Wysa cofounder and president, discusses how the startup tests its AI-backed chatbot to monitor safety and quality.
The startup announced a $5.5 million Series A raise in May 2021.
Also: Wysa receives FDA Breakthrough Device Designation for its mental health chatbot, and Pear Therapeutics expands its telehealth partnership program.
Also: MindPortal lands $5 million for its wearable noninvasive brain-computer device and Docbot raises $4 million for its GI-disease-detecting software.
Since the beginning of the pandemic there has been a 25% rise in health app downloads.
Wysa’s chatbot uses CBT and engages users in meditation, breathing yoga and aims to help people build resilience skills.
Here’s a look at how organizations are deploying artificial intelligence and machine learning for use cases ranging from doctor's assistants to social media and more.